February is when healthcare costs become very real for employers. Renewals hit, deductibles reset, and employees feel the squeeze at the pharmacy counter. Prescription drugs remain one of the fastest-growing expenses in every health plan. The good news? There’s finally a simpler, more predictable way to control it. What’s Happening in the Rx Market Where

Navigating Prescription Drug Costs in 2026: Insights from PwC, GAO, IQVIA, Navitus, Mercer, and Advisory Board Prescription drug expenses continue to represent one of the most rapidly increasing and challenging components of healthcare spending in the United States. In 2026, employers, benefits advisors, and consumers will encounter persistent issues related to opaque pricing, limited coverage,

Dear TotalRx.net Community,In the ever-evolving landscape of healthcare, where scientific ingenuity intersects with human resilience, we stand at the threshold of transformative possibilities. At TotalRx.net, we are committed to illuminating the path forward—not merely as observers of pharmaceutical progress, but as catalysts for a future where accessible, innovative treatments empower every individual to thrive. As

TotalRx Monthly Insights: Empowering Informed Choices in Prescription Care At TotalRx.net, our commitment extends beyond providing unparalleled access to prescription savings—we strive to serve as your trusted ally in navigating the complexities of pharmaceutical care. As a platform dedicated to delivering transparent, contracted rates with no deductibles or benefit caps, we equip individuals with tools

Welcome to Your TotalRx Update! Hey there! Grab a coffee and dive into the latest healthcare breakthroughs and wallet-saving tips. At TotalRx.net, we’re here to slice through the noise—and the greed—to bring you affordable meds and top-notch info. Let’s roll! Top Health News: FDA Approvals Spotlight The FDA’s been busy, and we’re unpacking the latest

Why did the pharmacist roll his eyes while filling a prescription? Because, with deductibles hitting $590 and patients paying $100 out-of-pocket for a common asthma inhaler like albuterol, he’s filling more complaints than prescriptions! FDA Approvals and New Drug Developments Wayrilz (rilzabrutinib): The U.S. Food and Drug Administration (FDA) approved Wayrilz on August 29, 2025,

Recent data shows significant frustration among Americans regarding the high cost of healthcare.According to a 2023 Harris Poll survey, more than 70% of U.S. adults feel the healthcare systemfails them in some way, with cost being the most common criticism. Additionally, a 2022 Associated Press-NORC poll found that over 70% of Americans believe theU.S. is

  The Special Drug Card Program: Maximizing Saving on FDA-approved Medicines. Medicine prices are skyrocketing at a rapid pace. In recent years, some critical medicines encountered a hike exceeding 20%. The surging price is drowning wallets and having a denting impact on people struggling to get the essential treatments. This growing crisis demands an urgent